Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bankole A Johnson

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Expert Opinion on Pharmacotherapy|May 26, 2006
A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependenceBankole A Johnson
Archives of Internal Medicine|August 16, 2006
New weapon to curb smoking: no more excuses to delay treatmentBankole A Johnson
Drugs of Today (Barcelona, Spain : 1998)|October 31, 2003
The role of serotonergic agents as treatments for alcoholismBankole A Johnson
Alcoholism, Clinical and Experimental Research|August 20, 2004
Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept studyBankole A Johnson
CNS Drugs|December 8, 2004
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatmentBankole A Johnson
Therapeutics and Clinical Risk Management|May 14, 2008
Naltrexone long-acting formulation in the treatment of alcohol dependenceBankole A Johnson
Alcoholism, Clinical and Experimental Research|January 25, 2017
Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use DisorderBankole A Johnson
Expert Review of Neurotherapeutics|April 28, 2005
Uses of topiramate in the treatment of alcohol dependenceBankole A Johnson
European Child & Adolescent Psychiatry|June 7, 2018
The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid featuresBankole A Johnson
The International Journal of Neuropsychopharmacology|April 3, 2001
Comment on 'Health aspects of cannabis: revisited' (Hollister)Bankole A. Johnson
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|May 26, 2006
A synopsis of the pharmacological rationale, properties and therapeutic effects of depot preparations of naltrexone for treating alcohol dependenceBankole A Johnson
Archives of Internal Medicine|August 16, 2006
New weapon to curb smoking: no more excuses to delay treatmentBankole A Johnson
Drugs of Today (Barcelona, Spain : 1998)|October 31, 2003
The role of serotonergic agents as treatments for alcoholismBankole A Johnson
Alcoholism, Clinical and Experimental Research|August 20, 2004
Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept studyBankole A Johnson
CNS Drugs|December 8, 2004
Role of the serotonergic system in the neurobiology of alcoholism: implications for treatmentBankole A Johnson
Therapeutics and Clinical Risk Management|May 14, 2008
Naltrexone long-acting formulation in the treatment of alcohol dependenceBankole A Johnson
Alcoholism, Clinical and Experimental Research|January 25, 2017
Toward Rational, Evidence-Based, and Clinically Relevant Measures to Determine Improvement Following Treatment for Alcohol Use DisorderBankole A Johnson
Expert Review of Neurotherapeutics|April 28, 2005
Uses of topiramate in the treatment of alcohol dependenceBankole A Johnson
European Child & Adolescent Psychiatry|June 7, 2018
The Maudsley's obsessional children: phenomenology, classification, and associated neurobiological and co-morbid featuresBankole A Johnson
The International Journal of Neuropsychopharmacology|April 3, 2001
Comment on 'Health aspects of cannabis: revisited' (Hollister)Bankole A. Johnson
Pageof 11